Efficacy of Itrifal Shahatra and Roghan Amla Khas in Inteshar Al-shar (Male Androgenetic Alopecia)-An open labelled Interventional clinical trial

ational Institute of Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Male Patients with age between 20-50 years
•2. Patient with mild to moderately severe male pattern hair loss according to Norwood-Hamilton classification scale Type II to VI (Excluding Type IIa, IIIa and III vertex)
•3. Patients who will give consent and able to do follow up

•1. Male patients below 20 and above 50 years
•2. Patients with Seborrheic dermatitis, Lichen planopilaris, Scalp psoriasis, Tinea Capitis, Alopecia areata, Trichotillomania and Scarring alopecia
•3. Patients suffering from systemic illnesses like HTN, DM, Malignancy, Liver or Kidney dysfunction
•4. Patients had received either CAM therapy or anti-androgenic medications or drugs causing hypertrichosis (phenytoin, acetazolamide, cyclosporine, diazoxide, psoralens, penicillamine, streptomycin and cortisone) or hypotrichosis (anti-coagulants, retinoids, lithium and beta blockers), use of finasteride or other 5-Î± reductase inhibitors or topical minoxidil within 01 month prior to enrolment
•5. Patients with surgical correction of scalp hair loss (hair transplant or scalp reduction)

发起方

ational Institute of Unani Medicine